Related Experiment Video

Updated: Jun 4, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

288

Insights into the emerging immune checkpoint NR2F6 in cancer immunity

Hayat Miftah1, Hamza Benthami1, Abdallah Badou1

  • 1LIGEP, Immuno-Genetics and Human Pathology Laboratory, Faculty of Medicine and Pharmacy, Hassan II University, Tarik Ibnou Ziad Street, P.O. Box 9154, Casablanca 20000, Morocco.

Journal of Leukocyte Biology
|December 26, 2024
PubMed

Insights

Nuclear receptor subfamily 2 group F member 6 (NR2F6) suppresses antitumor immunity, making it a potential target for cancer immunotherapy. Understanding NR2F6

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Nuclear receptor subfamily 2 group F member 6 (NR2F6) plays a critical role in immune regulation.
  • NR2F6 has been implicated in suppressing antitumor immune responses.
  • This suggests NR2F6 as a potential target for cancer immunotherapy.

Purpose of the Study:

  • To review the structure, functions, and expression of NR2F6.
  • To elucidate the role of NR2F6 in cancer immunity and progression.
  • To discuss the potential of NR2F6 as a prognostic biomarker and therapeutic target in cancer.

Main Methods:

  • Literature review of NR2F6 gene structure and biological functions.
  • Analysis of NR2F6 expression in immune and cancer cells.
  • Examination of NR2F6's role in cancer progression and patient outcomes.

Main Results:

  • NR2F6 exhibits complex gene structure and diverse biological functions.
  • NR2F6 is expressed in various immune and cancer cells, influencing cancer progression.
  • NR2F6 shows predictive significance for cancer patient outcomes.

Conclusions:

  • NR2F6 is a key regulator of cancer immunity, suppressing antitumor responses.
  • NR2F6 holds potential as a prognostic biomarker for cancer patients.
  • Targeting NR2F6 offers novel therapeutic strategies for cancer immunotherapy.
Keywords:
NR2F6cancer progressionimmune cellsimmune checkpointimmunosuppressionimmunotherapy

More Related Videos

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia05:24

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia

Published on: February 21, 2021

4.1K
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

236

Related Concept Videos

Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
1.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
844
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K